M

Mount Sinai Health System | The Spine Hospital at Mount Sinai - Department of Surgery

Research site
(Unclaimed)
Location
19 E 98th St, New York, New York, United States of America
Site insights

Top conditions

Carcinoma (3 trials)

Aneurysm (3 trials)

Chronic Renal Insufficiency (2 trials)

Plasma Cell Cancer (2 trials)

Head and Neck Cancer (2 trials)

Top treatments

Resmetirom
Dexamethasone
Natalizumab
Ursodiol
Narazaciclib
Folate
Cisplatin
Alprazolam
Magrolimab
ACR-368

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

6 of 34
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
A Phase 3 Study to Evaluate Safety and Biomarkers of Resmetirom (MGL-3196) in Patients With Non-alcoholic Fatty Liver Disease (NAFLD), MAESTRO-NAFLD-Open-Label-Extension (MAESTRO-NAFLD-OLE)

A 52-Week, Multi-center, Open-label, Active Treatment Extension Study to Evaluate Safety and Tolerability of Once Daily, Oral Administration of Resme...

Enrolling
Non-Alcoholic Fatty Liver Disease
Drug: Resmetirom

Purpose: To validate the safety and effectiveness of xBar monitoring tool for detection of post-operative anastomotic leaks in subjects undergoing re...

Not yet enrolling
Colorectal Surgery
Anastomotic Leak
Diagnostic Test: xBar system

This is an open label Phase 1b/2 study to evaluate the efficacy and safety of ACR-368 as monotherapy or in combination with ultralow dose gemcitabine...

Enrolling
Endometrial Adenocarcinoma
Urothelial Carcinoma
Drug: ACR-368
Diagnostic Test: OncoSignature

The Synchron motor neuroprosthesis (MNP) is intended to be used in subjects with severe motor impairment, unresponsive to medical or rehabilitative t...

Active, not recruiting
Stroke Brainstem
Spinal Cord Injuries
Device: Motor Neuroprosthesis (MNP)

The ProVent study is a randomized, open-label study designed to assess the efficacy of sipuleucel-T in reducing the progression of lower risk non-met...

Active, not recruiting
Adenocarcinoma of the Prostate
Biological: sipuleucel-T

A prospective, randomized, controlled study designed to assess whether digital virtual reality (VR) models, created from existing CT scans and MRIs,...

Active, not recruiting
Prostate Cancer
Device: Ceevra Reveal

Trial sponsors

Mount Sinai Health System logo

Mount Sinai Health System (6 trials)

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems